In contradiction, TANRIC’s survival analysis displayed better survival probability for those with higher expression of MRPL20-DT in bladder cancer (Kaplan–Meier analysis and log-rank test, p-value < 0.05), which comes in conformity with our results of it being downregulated in malignancy. This evidence concerns the gene MRPL20 and urinary bladder cancer.